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Abstract
Background: The organic polychlorinated compounds like dichlorodiphenyltrichloroethane with
its metabolites and polychlorinated biphenyls are a class of highly persistent environmental
contaminants. They have been recognized to have detrimental health effects both on wildlife and
humans acting as endocrine disrupters due to their ability of mimicking the action of the steroid
hormones, and thus interfering with hormone response. There are several experimental evidences
that they bind and activate human steroid receptors. However, despite the growing concern about
the toxicological activity of endocrine disrupters, molecular data of the interaction of these
compounds with biological targets are still lacking.
Results: We have used a flexible docking approach to characterize the molecular interaction of
seven endocrine disrupting chemicals with estrogen, progesterone and androgen receptors in the
ligand-binding domain. All ligands docked in the buried hydrophobic cavity corresponding to the
hormone steroid pocket. The interaction was characterized by multiple hydrophobic contacts
involving a different number of residues facing the binding pocket, depending on ligands orientation.
The EDC ligands did not display a unique binding mode, probably due to their lipophilicity and
flexibility, which conferred them a great adaptability into the hydrophobic and large binding pocket
of steroid receptors.
Conclusion: Our results are in agreement with toxicological data on binding and allow to describe
a pattern of interactions for a group of ECD to steroid receptors suggesting the requirement of a
hydrophobic cavity to accommodate these chlorine carrying compounds. Although the affinity is
lower than for hormones, their action can be brought about by a possible synergistic effect.
Background
The organic polychlorinated compounds like dichlo-
rodiphenyltrichloroethane (DDT) with its metabolites
(DDx) and polychlorinated biphenyls (PCBs) belongs to
a large family of highly persistent environmental pollut-
ants that are toxic for the endocrine function. They accu-
mulate in body tissues and fluids of exposed organisms,
including humans, and, because of their lipophilic nature,
are found at higher levels in adipose tissue, from which
are released upon weight loss [1]. These compounds have
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BMC Bioinformatics 2005, 6:S10been recognized to have detrimental health effects both
on wildlife and humans. Acting as endocrine disrupters
(EDC), they have been associated with several reproduc-
tive disorders in animals and humans [2] and have
become an important environmental concern. The alarm
is also related to the possible carcinogenicity of these com-
pounds for hormone related tumours. Endocrine disrupt-
ing effect is obtained by mimicking the action of the
steroid hormones, with which they share chemical charac-
teristics as the hydrophobicity and the presence of an aro-
matic ring, and thus by interfering with the hormone
response. Depending on the receptor targeted, they can
exert agonistic or antagonistic effects. Moreover, synthesis
and metabolism of natural hormones and levels of hor-
mone receptors can be altered by EDC [3]. Experimental
data "in vitro" show that DDT, PCB and metabolites com-
pete with estradiol for the binding with α and β estrogen
receptors with a relative affinity 1000–10000 times lower
[4]. Evidence of binding has been also reported for andro-
gen and progesterone receptors [5].
Despite the growing concern and the large amount of lit-
erature on the toxicological activity of EDC, molecular
data of the interaction of these compounds with biologi-
cal targets are still lacking.
With the aim to get insights, at molecular level, into the
binding mode of selected EDC to target receptors, we have
realized a set of computer-generated 3D models of human
estrogen, androgen and progesterone receptors complexes
with DDT and its metabolites DDE and DDD, and with
the PCB hydroxylated derivative (PCB-OH). The site of
interaction and the ligand conformation were predicted
by the use of molecular docking techniques. The results of
this computational study are here reported.
Results and discussion
Description of steroid receptors binding pocket
The crystal structures of ligand binding domains (LDBs)
of the steroid receptors in complex with the correspond-
ing natural hormones were used in this study: human
alpha estrogen receptor (hERα) in complex with estradiol
[6], human progesterone receptor (hPR) in complex with
progesterone [7] and rat androgen receptor (rAR) in com-
plex with dihydroxytestosterone [8].
Although several other X-ray complexes were available in
PDB, we decided to restrict the choice to the natural ster-
oid ligands to use target proteins under physiological con-
ditions. It is in fact known that steroid receptors undergo
to conformational changes after ligand binding and that
different ligands are responsible for different conforma-
tions. For example it has been reported that the binding of
antagonists (i.e. raloxifene) induce a conformational
change in estrogen receptor ligand region through the dis-
placement of helix 12 [9]. Rat androgen receptor was used
instead of human androgen receptor, as the latter was not
available in complex with the natural hormone. However,
in the ligand binding region, the human and the rat pro-
tein have identical sequence and the two structures super-
pose with a RMSD of 0.7Å.
Multiple alignment of the ligand binding domains of (hERα), (hPR) and (rAR)Figure 1
Multiple alignment of the ligand binding domains of 
(hERα), (hPR) and (rAR). Residues involved in ligand 
interactions are highlighted in yellow.
Molecular formulas of ligand compoundsFigure 2
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BMC Bioinformatics 2005, 6:S10The steroid hormone binding pocket is a hydrophobic
buried cavity. Visual inspection and structure superposi-
tion of the three receptors showed that the overall geom-
etry of the binding pocket is conserved. A preponderance
of hydrophobic residues can be observed. Hydrophilic or
charged residues stabilize the ligand interaction through
hydrogen bonds with the hydroxyl group of steroid mole-
cules.
Multiple alignment of hERα, hPR and rAR LDBs
sequences is shown in figure 1. The overall sequence iden-
tity of (hERα) is 29% with (hPR) and 25% with (rAR),
while (hPR) and (rAR) have 55% of identical residues.
Aminoacid residues involved in ligand interaction, as
deduced from the analysis of crystallographic structures,
are highlighted in yellow. The positions involved in the
binding are almost corresponding in the alignment of the
three structures.
Natural hormone ligands and a set of seven EDC mole-
cules (figure 2), were docked into the hormone binding
pocket of hERα, hPR and rAR with the purpose of study-
ing the interaction at a molecular level.
Docking simulations
We have used AutoDock3.05/ADT [10,11] and QXP [12]
programs to investigate the binding of ligands to recep-
tors. A preliminary global docking of the hormone lig-
ands, obtained from the crystal structures of each receptor,
was performed with AutoDock using a grid encompassing
the whole protein surface. For each receptor we ran a
docking experiment consisting of 100 simulations, which
were ranked in order of increasing docking energies values
and grouped in clusters of similar conformation (RMSD
0.5 Å). For all hormone ligands, the lowest energy solu-
tions, superposed to the crystallographic structures, dis-
played RMDS values from 0.49 to 0.6 Å, thus confirming
the agreement of the computational procedure applied
with X-ray experiment results. For the EDC ligands, the
hormone binding site was investigated with a local dock-
ing procedure using a smaller grid, focussed on the bind-
ing region. As a control, the X-ray ligands were also re-run
in local docking.
In a few cases (17-β-estradiol, Progesterone, Dihydrotes-
tosterone, p,p-DDE in hERα and PCB-OH in hPR), a sin-
gle cluster of solutions was found, among which the
possible binding conformation within active site will be
probably present.
In most cases, the solutions were grouped by AutoDock in
several clusters (3–10) with comparable binding energies.
From the structural analysis of the best solutions (lowest
energy) of each cluster, we could highlight differences in
the binding orientation.
Results from AutoDock simulations did not support the
hypothesis of a single binding mode of most EDC ligands
in complex with steroid receptors.
The AutoDock results were subjected to refinement with
the QXP program that allows the simultaneous flexibility
of ligand and active site chains. In addition, QXP allows
for the evaluation of the different energetic contributions
included in the energy function, giving the possibility of a
more specific comparison between different solutions.
QXP always confirmed AutoDock conformation predic-
tion when a unique solution was found. An example is
shown in figure 3 where the results of the two methods are
compared in the case of p,p-DDE docked into hERα.
When multiple conformations were obtained with Auto-
Dock simulation, QXP was able to predict, in most but
not all cases, a single binding mode. In these cases, the
lowest energy conformation was accepted. Figure 4
reports the example of docking simulation of o,p-DDT
docked to hERα. AutoDock results consisted of two solu-
tions with equivalent energy values (-31.1 vs. -30.8 kJ/
mol) but different binding mode (figure 4a). QXP refine-
ment of the two AutoDock solutions allowed to define a
unique binding mode by assigning different energy values
(-22.2 vs. -15.5 kJ/mol) to the two complexes (figure 4b).
The binding conformation associated to the lowest QXP
energy prediction is the selected solution. Its binding
mode superposed to an AutoDock result with a RMSD of
0.087 Å (figure 4c).
Comparison of AutoDock (red) and QXP (green) ligand con-for ation prediction for p,p-DDE ocked to hERαFigure 3
Comparison of AutoDock (red) and QXP (green) lig-
and conformation prediction for p,p-DDE docked to 
hERα. The solutions superposed with a RMSD = 0.015 Å.Page 3 of 8
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p,p DDD for hAr), QXP energy evaluation was not suffi-
cient to discriminate between different solutions. As for
these ligands no structural or mutagenesis data are availa-
ble, we could not rely on experimental indications to
select the most likely binding mode. Therefore, an evalu-
ation of hydrophobic contributions as long as visual
inspection and comparison of complexes to find a simi-
larity of orientation within an isomers group, were also
used as choice criteria. The final docking results used to
analyze the binding mode of ECD inside hormone recep-
tors satisfied the described criteria.
Binding mode
To study the mode of binding of EDC ligands, the best
docked complexes were subjected to LIGPLOT [13] analy-
sis that allows to identify and represent the ligand-protein
contacts. Residues involved in ligand binding are reported
Comparison of ligand conformation prediction for o,p-DDT docked to hERαFigure 4
Comparison of ligand conformation prediction for 
o,p-DDT docked to hERα. Panel a. Best scored solutions 
with AutoDock. Calculated binding energies were -31.1 kJ/
mol for solution 1 (red) and -30.8 kJ/mol for solution 2 (yel-
low). Panel b. Corresponding refinement with QXP: assigned 
total binding energies were -22.2 kJ/mol for pose 1 (green) 
and -15.5 kJ/mol for pose 2 (violet). Panel c. Structural super-
position of pose 1 from AutoDock and pose 1 from QXP 
(RMSD = 0.087 Å).
Table 1: Protein-ligand interactions obtained by LIGPLOT analysis of X-ray and QXP docked complexes. Bold and underlined: 
Residues shared by p,p- and o,p-isomers respectively for each receptor.
hERa hPR rAR
Estradiol L346,E353,L387,M388, R394,
F404,M421,H524L525,L539
Progesterone L718,N719,Q725,M759,
R766,L797,M801,Y890,
C891,T894,M909
Testosterone L704,N705,L707,G708,
Q711,M742,M745,M749,
R752,F764,M780,M787,
F876,T877, F891,M895
p,p-DDT W383,L384,L387,G521,L525,
A350,L391
L715,L718,F778 
N719,G722,F905
M745,F764,M780 
L704,L707,W741
p,p-DDE W383,L384,L387,G521, L525 
F404
L715,L718,F778 M756 M745,F764,M780 
W741, M742, L873, T877
p,p-DDD W383,L384,L387 G521, L525 
L346, A350, F404,L540
L715,L718,F778 
C891, F905, M909
M745, F764,M780 
L704, L707, M787,L873
o,p-DDT L346,A350, F404,M421
M343,L349,L384,L387,M388,
I424,F425,L428,G521,H524,
L525
L718,F778
L715,N719,G722,W755,
M756,M759,F794,M801
T894,V903,F905,M909
L704, F764,M780,L873
L707, M787
o,p-DDE L346,A350,F404,M421,
M343,L525
L718, F778
T890, C891, T894, F905
L704, F764,M780,L873
W741, M745, F876, T877
o,p-DDD L346,A350, F404,M421
L384, L387, M388, I424, F425,
L428
L718, F778
L721, M759, F794, L797, 
Y890, M909
L704, F764,M780,L873
L707,M742, M745,F876
PCB-OH M343,L346,T347,A350 L387,
M388,L391,F404 G521,H524
L715,L718,L721,V760,
L763,F778, L797,M801 
Y890,C891
L701,L704,N705,L707,
Q711,W741,M742 M745,
F764,L873,F876Page 4 of 8
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BMC Bioinformatics 2005, 6:S10in table 1. As expected, the type of interaction is mainly
hydrophobic, due to the lipophilic character of the lig-
ands. Hydrophilic residues are involved in the binding of
PBC-OH that establish a H-bond through a hydroxyl
group. As an example, the complex with hERα is repre-
sented in figure 5. Estradiol is superposed for comparison.
Some of the residues involved in ligand binding are com-
mon to estradiol (orange in figure 5), including H524,
which forms hydrogen bonds with both ligands.
We could not find an overall consensus for the residues
involved in EDC binding. However, the two groups of iso-
mers were found to establish contacts with common resi-
dues within a specific receptor. p,p-DDx ligands showed a
pattern of interaction with hERα involving 5 common res-
idues and some partially shared interactions (see table 1).
They displayed a very similar orientation in the binding
pocket (figure 6a), and the superposition of the docked
conformers gave RMSD values ranging from 0.047 to
0.074 Å. A similar result was obtained for hPR (figure 6b).
In the case of binding to androgen receptor, a group of 3
common residues were involved. Ligands orientation was
similar for p,p-DDT and p,p-DDE with the two phenyl
rings slightly rotated, while p,p-DDD was translated with
respect to the others two (figure 6c).
Predicted orientations of o,p-isomers showed similarities
only when bound to progesterone receptor: correspond-
ing portions of the ligand molecules were involved in the
contacts with protein (figure 6e). Binding to estrogen and
androgen receptors was predicted with markedly different
orientations of ligands that shared contacts with common
residues but involving different portions of the molecule
(figure 6d and 6f). This behaviour is in contrast with the
hormone molecule which is rigid and almost planar while
DDx are flexible and can assume several possible orienta-
tions. Moreover they lack of the presence of those
hydroxyl groups that anchor the hormone in the binding
site through hydrogen bonds with charged or hydrophilic
groups. Finally, the EDC ligands, highly hydrophobics
and smaller than hormones, can be accommodated with
multiple conformations in a wide binding cavity mainly
lined by hydrophobic residues. Because of these character-
istics, the specificity of binding is lower than for hormone
ligands. We found that QXP calculated free energies of
binding were in all cases higher for EDC than for hor-
mone ligands (table 2): for example in hERα, binding
energy raised from -36.7 to -13.4 kJ/mol from estradiol to
p,p-DDT. The only exception is the o,p-DDE bound to
hPR for which a ∆G value comparable to progesterone was
found (-25.0 vs. -26.3 kJ/mol). In general, o,p-isomers
show higher affinity for all tested receptors compared to
p,p-DDx and PCB-OH. Our data confirm the hypothesis
of mild toxicity of EDC, in agreement with evidences from
competition experiments [14,15]. However, because of
the low selectivity and great adaptability, EDC toxicity
might be amplified by a synergic effect.
Predicted binding of PCB-OH with hERαFigure 5
Predicted binding of PCB-OH with hERα. Yellow: PCB-
OH, Violet : estradiol; ligand oxygen atoms are in red, and 
chlorine atoms in green. Aminoacids color code: orange: res-
idues involved in ligand binding common to estradiol and 
PCB-OH; blue: PCB-OH specific interaction.Green dashed 
lines: hydrogen bonds
Table 2: Estimated binding energies (kJ/mol) obtained by QXP simulation for tested ligands docked to steroid receptors.
hERα hPR rAR
1) Estradiol -36.7
2) Progesterone -26.3
3) Testosterone -30.4
4) p,p-DDT -13.4 -16.6 -14.8
5) p,p-DDE -10.7 -14 -13.4
6) p,p-DDD -12.4 -17.1 -12.7
7) o,p-DDT -22.2 -17.8 -22.8
7) o,p-DDE -19.2 -25.0 -12.8
9) o,p-DDD -17.3 -14.0 -15.9
10) PCB-OH -8.6 -10.6 -14.7Page 5 of 8
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The purpose of this work was to describe the molecular
interactions between steroid receptors and some endo-
crine disrupting pollutants. The complexes were modelled
starting from the X-ray coordinates of the receptors and
simulating the ligand binding by a combination of flexi-
ble docking. Subsequent structural analysis of the models
provided information on the binding mode. In general,
this was characterized by multiple hydrophobic contacts
which engaged a different number of residues facing the
binding pocket, depending on the ligands orientation.
The EDC ligands did not display a unique mode of bind-
ing, probably due to their lipophilicity, their flexibility
and their small volume, which conferred them a great
adaptability in the hydrophobic and large binding pocket
of steroid receptors.
A wider exploration of the binding of steroid receptors
with other classes of EDC compounds is already in
progress. Further investigations of their binding proper-
ties at molecular level will provide useful information for
the prediction of the toxicity of compounds that are
released in the environment and also for the rational
design and synthesis of new molecules with low impact
on human health.
Methods
Preparation of the ligand and receptor molecules for 
docking
Molecular structures of the EDC ligands (namely p,p-
DDT, o,p-DDT, p,p- DDE, o,p-DDE, p,p- DDD, o,p-DDD,
PCB-OH) were built and energy minimized with Macro-
Model [Schrödinger LLC and 16 ], the resulting
geometries were re-optimized with semi-empirical quan-
tum mechanic calculations, using the Hamiltonian AM1
as implemented in Spartan 'O2, (Wavefunction Inc.,
Irvine, CA).
To model the receptor-ligand complexes, the coordinates
of human estrogen α (hERα) [PDB:1G50], progesterone
(hPR) [PDB:1A28] and rat androgen (rAR) [PDB:1I37]
receptors in complex with the corresponding steroid hor-
mone (estradiol, progesterone, and dihydrotestosterone
respectively) were used.
The receptors and the ligand were prepared for docking
using ADT, the AutoDock tool graphical interface [11].
For each receptor structure polar hydrogens were added,
Kollman charges were assigned and atomic solvatation
parameters were added. For the ligands, polar hydrogen
charges of the Gasteiger-type were assigned and the non-
polar hydrogens were merged with the carbons. The inter-
nal degrees of freedom and torsions were set for each
EDC.
Docking simulations
A two-step docking protocol was employed. In a first
phase, each inhibitor was docked into the active site by
means of the program AutoDock3.05 [10] with the mac-
romolecule held fixed and the ligands being flexible. The
region of interest used by AutoDock was first the whole
receptor protein and then was defined in such a way to
include a specific portion of the binding site of the macro-
molecule, as described above. A smaller grid, focussed on
the binding region, was used and the number of simula-
tions was set to 50. In particular, affinity maps for all the
atom types present, as well as an electrostatic map, were
computed with a grid spacing of 0.375 Å. The search was
carried out with the Lamarckian Genetic Algorithm: pop-
ulations of 250 individuals with a mutation rate of 0.02
have been evolved for 10 millions generations. Evaluation
of the results was done by sorting the different complexes
with respect to the predicted binding energy. A cluster
analysis based on root mean square deviation values, with
reference to the starting geometry, was subsequently per-
formed.
This first step approach served only to accommodate the
different ligands into the binding site. The structural mod-
els collected from the lowest-energy docking solution of
each cluster of AutoDock, have been used as input for
QXP docking [9]. The algorithm implemented in the QXP
program allows for fully flexibility of the inhibitors and
simultaneous flexibility of the active site side-chains. The
starting structure was previously optimized by energy
minimization. Then, each docking run included 50 cycles
of Monte Carlo perturbation, subsequent fast searching,
and final energy minimisation. For each single docking
QXP simulation the results were evaluated in terms of
total estimated binding energy, internal strain energy of
the ligand, van der Waals and electrostatic interaction
energies.
All calculations were performed on Octane and O2 SGI
workstations and on Linux Cluster of 9 workstations each
equipped with 2 processors AMDx64 and 2 GB RAM.
Figures were realized with InsightII (Accelrys) and PyMOL
Molecular Graphics System (DeLano Scientific, San Car-
los, CA, USA).
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Docking results for p,p-isomers on the left and o,p-isomers on the rightFigure 6
Docking results for p,p-isomers on the left and o,p-isomers on the right. Panels a and d refers to hERα, b and e to 
hPR, c and f to rAR. Residues shared by p,p- and o,p-isomers respectively for each receptor are coloured in orange. Ligands 
color code: red:p,p- and o,p-DDT; yellow: p,p- and o,p-DDE; purple: p,p- and o,p-DDD; green: chlorine atoms.
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